Effect of ceftazidime, amikacin and ciprofloxacin on biofilm formation by some enterobacterial clinical isolates

Chemotherapy

Volumn 50, Issue 5, 2004, Pages 255-259

  Bret, Laurent ^a   Di Martino, Patrick ^b  

^a UNIVERSITÉ DE CERGY PONTOISE   (France)

^b UNIVERSITÉ DE CERGY PONTOISE   (France)

Author keywords

Antibiotics; Biofilm; Enterobacteria; Infections; Nosocomial infections; Sub minimal inhibitory concentrations; Uropathogens

Indexed keywords

AMIKACIN; CEFTIZOXIME; CIPROFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS VULGARIS; PROVIDENCIA STUARTII;

AMIKACIN; BIOFILMS; CATHETERS, INDWELLING; CEFTAZIDIME; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROBACTERIACEAE; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYSTYRENES; URINARY CATHETERIZATION;

EID: 9144241998     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081947     Document Type: Article

References (33)

1. Kumon H, Hashimoto H, Nishimura M, Monden K, Ono N: Catheter-associated urinary tract infections: Impact of catheter materials on their management. Int J Antimicrob Agents 2001;17:311-316.
2. Wazait HD, Patel HR, Veer V, Kelsey M, Van Der Meulen JH, Miller RA, Emberton M: Catheter-associated urinary tract infections: Prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). BJU Int 2003;91:806-809.
3. Stickler D: Biofilms. Curr Opin Microbiol 1999;2:270-275.
4. Pratt LA, Kolter R: Genetic analysis of Escherichia coli biofilm formation: Roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 1998;30:285-293.
5. Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C: Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: Role of flagella, curli and colanic acid. Environ Microbiol 2000;4:450-464.
6. Di Martino P, Cafferini N, Joly B, Darfeuille-Michaud A: Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol 2003;154:9-16.
7. Vidal O, Longin R, Prigent-Combaret C, Dorel C, Hooreman M, Lejeune P: Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: Involvement of a new ompR allele that increases curli expression. J Bacteriol 1998;180:2442-2449.
8. Adams JL, McLean RJ: Impact of rpoS deletion on Escherichia coli biofilms. Appl Environ Microbiol 1999;65 :4285-4287.
9. Dorel C, Vidal O, Prigent-Combaret C, Vallet I, Lejeune P: Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation. FEMS Microbiol Lett 1999;178:169-175.
10. Jackson DW, Simecka JW, Romeo T: Catabolite repression of Escherichia coli biofilm formation. J Bacteriol 2002;184:3406-3410.
11. Jackson DW, Suzushi, K, Oakford L, Simecka JW, Hart ME, Romeo T: Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol 2002;184:290-301.
12. Di Martino P, Merieau A, Phillips R, Orange N, Hulen C: Isolation of an Escherichia coli strain mutant unable to form biofilm on polystyrene and to adhere to human pneumocyte cells: Involvement of tryptophanase. Can J Microbiol 2002;48:132-137.
13. Di Martino P, Fursy R, Bret L, Sundararaju B, Phillips R: Indole can act as an extracellular signal to regulate biofilm formation in Escherichia coli and in other indole-producing bacteria. Can J Microbiol 2003;49:443-449.
14. Jouenne T, Tresse O, Junter G-A: Agar-entrapped bacteria as an in vitro model of biofilms and their susceptibility to antibiotics. FEMS Microbiol Lett 1994;119:237-242.
15. Coquet L, Junter G-A, Jouenne T: Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. J Antimicrob Chemother 1998;42:755-760.
16. Vilain S, Cosette P, Junter G-A, Jouenne T: Phosphate deprivation is associated with high resistance to latamoxef of gel-entrapped, sessile-like, Escherichia coli cells. J Antimicrob Chemother 2002;49:315-320.
17. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W: Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesion expression in biofilm-forming Staphyloccocus epidermidis. Antimicrob Agents Chemother 2000;44:3357-3363.
18. Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T: Effect of clarithromycin on Pseudomonas aeruginosa biofilms. Chemotherapy 2000;46:36-42.
19. Reid G, Habash M, Vachon D, Denstedt J, Riddell J, Beheshti M: Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation. Int J Antimicrob Agents 2001;17:317-320.
20. Vranez J: Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. Chemotherapy 1996;42:177-185.
21. Braga PC, Dal Sasso M, Sala MT: Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. J Antimicrob Chemother 2000;45:15-25.
22. Baskin H, Dogan Y, Bahar H, Yulug N: Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli. Int J Antimicrob Agents 2002;19:79-82.
23. Balague C, Fernandez L, Perez J, Grau R: Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates. J Antimicrob Chemother 2003;51:401-404.
24. Stickler D, Morris N, Moreno M-C, Sabbuba N: Studies on the formation of crystalline bacterial biofilms on urethral catheters. Eur J Clin Microbiol Infect Dis 1998;17:649-652.
25. Kondo F, Satoh S: Effects of subminimal inhibitory concentrations of beta-lactam antibiotics against R-plasmid-bearing bacteria. Chemotherapy 1995;41:125-133.
26. Drago L, De Vecchi E, Mombelli B, Nicola L, Valli M, Gismondo MR: Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother 2001;48:37-45.
27. Di Martino P, Rebière-Huët J, Hulen C: Effects of antibiotics on adherence of Pseudomonas aeruginosa and Pseudomonas fluorescens to A549 pneumocyte cells. Chemotherapy 2000;46:129-134.
28. Di Martino P: Effects of antibiotics on adherence of Pseudomonas aeruginosa and Pseudomonas fluorescens to human fibronectin. Chemotherapy 2001;47:344-349.
29. Trafny EA, Stepinska M, Antos M, Grzybowski J: Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I. Antimicrob Agents Chemother 1995;39:2645-2649.
30. Ichimiya T, Yamasaki T, Nasu M: In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 1994;34:331-341.
31. Ichimiya T, Takeoka K, Hiramatsu K, Hirai K, Yamasaki T, Nasu M: The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 1996;42:186-191.
32. Kjelleberg S, Molin S: Is there a role for quorum sensing signals in bacterial biofilms? Curr Opin Microbiol 2002;5:254-258.
33. Sofer D, Gilboa-Garber N, Belz A, Garber NC: 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 1999;45:335-341.